Benzinga | Mar 1, 2021 04:14PM EST

Regenxbio Q4 EPS $(1.24) Down From $(0.72) YoY, Sales $21.45M Up From $11.77M YoY

Regenxbio (NASDAQ:RGNX) reported quarterly losses of $(1.24) per share. This is a 72.22 percent decrease over losses of $(0.72) per share from the same period last year. The company reported $21.45 million in sales this quarter. This is a 82.23 percent increase over sales of $11.77 million the same period last year.